Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rare association between cystic fibrosis, Chiari I malformation, and hydrocephalus in a baby: a case report and review of the literature

Journal of Medical Case Reports20115:366

https://doi.org/10.1186/1752-1947-5-366

Received: 22 December 2010

Accepted: 12 August 2011

Published: 12 August 2011

Abstract

Introduction

Cystic fibrosis, an epithelial cell transport disorder caused by mutations of the cystic fibrosis transmembrane conductance regulator gene, is not generally associated with malformations of the central nervous system. We review eight previously published reports detailing an infrequent association between cystic fibrosis and Chiari I malformation.

Case presentation

To the best of our knowledge, our report describes only the ninth case of a baby presenting with a new diagnosis of cystic fibrosis and Chiari I malformation, in this case in a 10-month-old, full-term Caucasian baby boy from the United States of America. Neurosurgical consultation was obtained for associated developmental delay, macrocephaly, bulging anterior fontanel, and papilledema. An MRI scan demonstrated an extensive Chiari I malformation with effacement of the fourth ventricle, obliteration of the outlets of the fourth ventricle and triventricular hydrocephalus without aqueductal stenosis. Our patient was taken to the operating room for ventriculoperitoneal shunt placement.

Conclusions

It is possible that the cystic fibrosis transmembrane conductance regulator gene may play a previously unrecognized role in central nervous system development; alternatively, this central nervous system abnormality may have been acquired due to constant valsalva from recurrent coughing or wheezing or metabolic and electrolyte imbalances that occur characteristically in cystic fibrosis.

Introduction

Cystic fibrosis (CF) is a disorder in which transepithelial ion transport affects fluid secretion in exocrine glands and the epithelium of the respiratory, gastrointestinal, and reproductive tracts [1]. Although developmental abnormalities of the male genital tract are commonly associated with CF, malformations of other organ systems, particularly the central nervous system (CNS), are rarely associated with the disorder.

Chiari I malformation, defined by herniation of the cerebellar tonsils below the foramen magnum, is associated with hydrocephalus in 7% to 10% of cases [2, 3]. Hydrocephalus often originates in the fourth ventricular outflow obstruction. An association between Chiari I malformation and cystic fibrosis has only been reported in the literature three times[46]. In the eight previously-reported patients with Chiari malformation, six patients had a known CF diagnosis, and two had an autopsy CF diagnosis. Here, we add the case of a ninth patient to the literature; a 10-month-old baby with a diagnosis of CF and associated Chiari I malformation and hydrocephalus. We also discuss the unusual association of these conditions.

Case presentation

A 10-month-old, full-term Caucasian baby boy from the United States of America with a history of multiple respiratory infections, persistent cough, and greasy stools since birth, presented to our facility with failure to thrive and a one-week history of emesis. Our patient had a positive sweat chloride test result, confirming a new diagnosis of CF. Upon physical examination, we discovered he had macrocephaly with a head circumference in the 98th percentile, splaying of the sutures, and a bulging fontanel. A fundoscopic examination demonstrated papilledema. The remainder of his physical examination was unremarkable.

Imaging studies demonstrated Triventricular hydrocephalus and severe Chiari I malformation with 2.2cm of cerebellar tonsillar herniation to the C3 level (Figure 1). Our patient did not have Chiari malformation symptoms at this time and was without signs of spinal cord compression or cerebellar or brainstem dysfunction. Therefore, we elected to treat the hydrocephalus first and followed our patient closely for the development of a problematic Chiari malformation.
Figure 1

Mid-sagittal T1 weighted MRI of the brain shows tonsillar herniation to the level of C3. There is effacement of the fourth ventricle and Triventricular hydrocephalus.

Our patient was brought into the operating room for ventriculoperitoneal shunt (VPS) placement. The opening pressure was noted to be approximately 25 cm H2O upon cannulation of the ventricular system. The rest of the operation proceeded in standard fashion.

Our patient did well after surgery; he had no continued signs and symptoms of increased intracranial pressure and was discharged home the following day. At one-year follow-up with the Cystic Fibrosis Clinic and the Neurosurgery Service, our patient was continuing to do well with no signs or symptoms of increased intracranial pressure or problematic Chiari malformation.

Discussion

CF and Chiari I malformation

CF is an autosomal recessive disorder characterized by abnormal chloride conduction across epithelial membranes. It is the most common lethal genetic disease in the Caucasian population, with an incidence of one in 1500 to one in 4000 live births [1].

An association between CF and Chiari malformation has been previously reported in eight patients (Table 1) [46]. Rusakow et al. described a seven-year-old Hispanic girl with cystic fibrosis from homozygous delta F508 mutations who had cervicothoracic syringomyelia and a Chiari I malformation [6].
Table 1

Previous reports of cystic fibrosis (CF) and Chiari malformation

Reference

Age

Sex

Presenting signs and symptoms

Radiologic findings (extent of Chiari, ± aqueductal stenosis, ± hydrocephalus)

Treatment

Follow-up

Outcome

[10]

10 months

M

Swallowing dysfunction

Not reported

Chiari decompression

Not reported

Resolution of symptoms

[10]

18 years

M

Syncope

Not reported

Chiari decompression

Not reported

Resolution of symptoms

[10]

17 years

F

Numbness of extremities

Not reported

Chiari decompression

Not reported

Resolution of symptoms

[10]

three years

M

Recurrent vomiting

Not reported

None

Not reported

Symptoms unresolved

[10]

17 years

M

Persistent headache

Not reported

Chiari decompression

Not reported

Resolution of symptoms

[13]

four months

M

Failure to thrive

Aqueductal stenosis; hydrocephalus

VP shunt

three months

Death from sepsis

[13]

eight months

F

Failure to thrive, nystagmus

Tonsillar herniation with hydrocephalus

Chiari decompression and VP shunt

one year

Shunt malfunction and cerebral herniation

[15]

eight years

F

Thoracic scoliosis; gait instability; hand wasting

Chiari I with thoracic scoliosis and cervicothoracic syrinx

Chiari decompression

two months

Resolution of symptoms

Present report

10 months

M

Vomiting

2.2 cm of herniation; aqueductal stenosis; hydrocephalus

VP shunt

one month

Resolution of symptoms

VP = ventriculoperitoneal.

Needleman et al. described five patients who were known to have CF and were diagnosed with Chiari malformation after developing various neurological symptoms [4]. There were four males and one female ranging from 10 months to 18 years old. One of the patients was homozygous for the delta F508 mutation, while the others were heterozygous. In two patients, the second mutations could not be identified, while the remaining patients showed G542X and W1282X as their second mutation, respectively. The authors concluded that when patients with cystic fibrosis have unexplained neurological issues, Chiari I malformation is likely.

Rakheja et al. described two babies with a known diagnosis of Chiari I malformation and hydrocephalus; however, the CF diagnosis was not made until after death [5]. At presentation, the two patients, one boy and one girl, were four months and eight months old, respectively. One patient underwent Chiari decompression followed by shunt placement; the other underwent VPS placement as the initial treatment. The four-month-old boy died a month after surgery from acute bronchopneumonia leading to Pseudomonas aeruginosa sepsis. The eight-month-old girl died a year after surgery from increased intracranial pressure and possible shunt obstruction.

The mechanism of an association between cystic fibrosis and Chiari I malformation is unknown. It does not appear that the association is due to a specific type of cystic fibrosis transmembrane conductance regulator (CFTR) mutation as several different point mutations have been described in patients with both conditions [5]. It is possible that the CFTR gene plays an unrecognized role in CNS development. CFTR mRNA and protein expression have been identified in the developing human hypothalamus where the protein may be involved in neuropeptide vesicle trafficking [7, 8]. Children with newly-diagnosed CF have transiently-elevated intracranial pressure which is thought to be due to either vitamin A deficiency, a response to treatment of their malnutrition [9], or intermittent valsalva from persistent, chronic wheezing or coughing [10, 11]. Vitamin A also affects the development of this CNS/skeletal abnormality, as it induces abnormal cranial vault development and herniation of the cerebellum in hamster embryos [12].

Chiari I malformation and hydrocephalus

In 1891, Hans Chiari was the first to describe the cerebellar tonsils descending below the foramen magnum [13]. However, the origin and pathophysiology of this condition remains poorly understood. Generally considered a congenital anomaly, some reports suggest that Chiari I malformation may be a sequelae of intracranial hypertension [14]. In his 1891 monograph, Chiari originally surmised that hydrocephalus pushed the cerebellar tonsils into the foramen magnum. But overt hydrocephalus is only reported in 7% to 10% of patients with symptomatic Chiari I malformation [15]. However, others have asserted that Chiari I malformation is a developmental anomaly of the posterior fossa with subsequent arachnoid adhesions, thought to be due to repeated trauma [16]. Therefore, any associated hydrocephalus may be due to fourth ventricular outflow obstruction [17]. It is possible that persistent coughing in CF could lead to arachnoid adhesions and altered CSF dynamics, resulting in hydrocephalus. This remains to be studied.

Krayenbuhl reported that 20 of 22 patients with symptomatic Chiari I malformation who were initially treated with ventriculoatrial shunt placement experienced symptom improvement [16]. Endoscopic third ventriculostomy may be an alternative to ventricular shunt placement for hydrocephalus associated with Chiari I malformation [15].

Conclusions

In summary, we describe the case of a 10-month-old baby boy with a new diagnosis of CF and, later, Chiari malformation and hydrocephalus after presenting with developmental delay, macrocephaly, bulging anterior fontanel, and papilledema. We hypothesize that the CF precipitated the Chiari malformation although the mechanism is unclear. The extensive Chiari malformation then caused obstruction at the fourth ventricle outlets and resulted in hydrocephalus. Because of the young age of our patient, we elected to treat him with a VPS. His long-term clinical outcome remains to be determined.

Consent

Written informed consent was obtained from the patient's next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Acknowledgements

The authors would like to recognize Lily Chun for her editorial assistance in the production of this manuscript.

Authors’ Affiliations

(1)
Division of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine

References

  1. Schofield D, Cotran RS: Diseases of infancy and childhood. Robbins Pathologic Basis of Disease. Edited by: Cotran RS, Kumar V, Collins T. 1999, Philadelphia, PA: WB Saunders, 477-481. 6Google Scholar
  2. Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC: Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery. 1999, 44: 1005-1017. 10.1097/00006123-199905000-00042.View ArticlePubMedGoogle Scholar
  3. Tubbs RS, McGirt MJ, Oakes WJ: Surgical experience in 130 pediatric patients with Chiari I malformations. J Neurosurg. 2003, 99: 291-296. 10.3171/jns.2003.99.2.0291.View ArticlePubMedGoogle Scholar
  4. Needleman JP, Panitch HB, Bierbrauer KS, Schidlow DV: Chiari type I malformation in children and adolescents with cystic fibrosis. Pediatr Pulmonol. 2000, 30: 490-492. 10.1002/1099-0496(200012)30:6<490::AID-PPUL9>3.0.CO;2-I.View ArticlePubMedGoogle Scholar
  5. Rakheja D, Xu Y, Burns DK, Veltkamp DL, Margraf LR: Cystic fibrosis and Chiari type I malformation: autopsy study of two infants with a rare association. Pediatr Dev Pathol. 2003, 6: 88-93. 10.1007/s10024-002-0021-1.View ArticlePubMedGoogle Scholar
  6. Rusakow LS, Guarin M, Lyon RM, Splaingard ML: Syringomyelia and chiari malformation presenting as scoliosis in cystic fibrosis. Pediatr Pulmonol. 1995, 19: 317-318. 10.1002/ppul.1950190512.View ArticlePubMedGoogle Scholar
  7. Mulberg AE, Weyler RT, Altschuler SM, Hyde TM: Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus. Neuroreport. 1998, 9: 141-144. 10.1097/00001756-199801050-00028.View ArticlePubMedGoogle Scholar
  8. Weyler RT, Yurko-Mauro KA, Rubenstein R, Kollen WJ, Reenstra W, Altschuler SM, Egan M, Mulberg AE: CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am J Physiol. 1999, 277: C563-571.PubMedGoogle Scholar
  9. Roach ES, Sinal SH: Initial treatment of cystic fibrosis. Frequency of transient bulging fontanel. Clin Pediatr (Phila). 1989, 28: 371-373. 10.1177/000992288902800807.View ArticleGoogle Scholar
  10. Dure LS, Percy AK, Cheek WR, Laurent JP: Chiari type I malformation in children. J Pediatr. 1989, 115: 573-576. 10.1016/S0022-3476(89)80283-5.View ArticlePubMedGoogle Scholar
  11. Pascual J, Iglesias F, Oterino A, Vazquez-Barquero A, Berciano J: Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology. 1996, 46: 1520-1524.View ArticlePubMedGoogle Scholar
  12. Marin-Padilla M, Marin-Padilla T-M: Morphogenesis of experimentally induced Arnold--Chiari malformation. J Neurol Sci. 1981, 50: 29-55. 10.1016/0022-510X(81)90040-X.View ArticlePubMedGoogle Scholar
  13. Chiari H: Concerning alterations in the cerebellum resulting from cerebral hydrocephalus. 1891. Pediatr Neurosci. 1987, 13: 3-8. 10.1159/000120293.View ArticlePubMedGoogle Scholar
  14. Payner TD, Prenger E, Berger TS, Crone KR: Acquired Chiari malformations: incidence, diagnosis, and management. Neurosurgery. 1994, 34: 429-434. 10.1227/00006123-199403000-00007.View ArticlePubMedGoogle Scholar
  15. Banerji NK, Millar JH: Chiari malformation presenting in adult life. Its relationship to syringomyelia. Brain. 1974, 97: 157-168. 10.1093/brain/97.1.157.View ArticlePubMedGoogle Scholar
  16. Krayenbuhl H: Evaluation of the different surgical approaches in the treatment of syringomyelia. Clin Neurol Neurosurg. 1975, 77: 111-128.PubMedGoogle Scholar
  17. Hayhurst C, Osman-Farah J, Das K, Mallucci C: Initial management of hydrocephalus associated with Chiari malformation type I-syringomyelia complex via endoscopic third ventriculostomy: an outcome analysis. J Neurosurg. 2008, 108: 1211-1214. 10.3171/JNS/2008/108/6/1211.View ArticlePubMedGoogle Scholar

Copyright

© Patel et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.